$1.13
0.88% yesterday
Nasdaq, May 23, 10:00 pm CET
ISIN
US81362J1007
Symbol
VANI

Second Sight Medical Products, Inc. Stock price

$1.13
+0.10 9.71% 1M
-0.24 17.52% 6M
-0.03 2.59% YTD
-0.50 30.67% 1Y
-4.90 81.26% 3Y
-1.66 59.49% 5Y
-304.39 99.63% 10Y
Nasdaq, Closing price Fri, May 23 2025
-0.01 0.88%
ISIN
US81362J1007
Symbol
VANI
Sector

Key metrics

Market capitalization $66.95m
Enterprise Value $53.94m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 5.76
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-25.01m
Free Cash Flow (TTM) Free Cash Flow $-21.82m
Cash position $13.01m
EPS (TTM) EPS $-0.42
P/E forward negative
Short interest 0.88%
Show more

Is Second Sight Medical Products, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Second Sight Medical Products, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Second Sight Medical Products, Inc. forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Second Sight Medical Products, Inc. forecast:

Buy
100%

Financial data from Second Sight Medical Products, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 8.77 8.77
11% 11%
-
- Research and Development Expense 16 16
3% 3%
-
-25 -25
6% 6%
-
- Depreciation and Amortization 0.40 0.40
14% 14%
-
EBIT (Operating Income) EBIT -25 -25
6% 6%
-
Net Profit -24 -24
6% 6%
-

In millions USD.

Don't miss a Thing! We will send you all news about Second Sight Medical Products, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Second Sight Medical Products, Inc. Stock News

Positive
Seeking Alpha
4 days ago
Here's the next batch of weird science stocks that have market darling potential. I'm tracking five meme-worthy, deep science sectors: brain-computer interfaces, CRISPR/gene editing, organoids, programmable cell therapy, and room-temperature superconductors. Monitor each sector's stocks poised to soar if a major tech player announces a breakthrough.
Neutral
GlobeNewsWire
11 days ago
All subjects in the NPM-115 cohort had successful insertions of a miniature, ultra long-acting GLP-1 (exenatide) implant in the on-going LIBERATE-1™ study in obese or overweight individuals; top-line results are anticipated in mid-2025
Neutral
GlobeNewsWire
17 days ago
ALAMEDA, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, Ph.D., will present and participate in a panel discussion at the American Association of Pharmaceutical Scientists' (AAPS) “Beyond GLP1s: Wher...
More Second Sight Medical Products, Inc. News

Company Profile

Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It operates through the following geographical segments: United States, Italy, France, and China. The firm's product include Argus II Retinal Prosthesis System that treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA.

Head office United States
CEO Adam Mendelsohn
Employees 37
Founded 2003
Website vivani.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today